The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial

Inclusion Criteria: * Subject indicated and scheduled for WATCHMAN device implantation at IHVI (Inova Heart and Vascular Institute) * Subject may be of either sex and of any race, and must be \>18 years of age. * Subject must be willing and able to give appropriate informed consent. * The subject is able to read and has signed and dated the informed consent document including authorization permitting release of personal health information approved by the investigator's Institutional Review Board (IRB). Exclusion Criteria: * Subjects with contraindications for WATCHMAN device implantation Intracardiac thrombus is visualized by echocardiographic imaging, An atrial septal defect repair or closure device or a patent foramen ovale repair or closure device is present, The LAA (Left atrial appendage) anatomy will not accommodate a device, Any of the customary contraindications for other percutaneous catheterization procedures (e.g., patient size too small to accommodate TEE - transesophageal echocardiography probe or required catheters) or conditions (e.g., active infection, bleeding disorder) are present, There are contraindications to the use of warfarin, aspirin, or clopidogrel, The patient has a known hypersensitivity to any portion of the device material or the individual components such that the use of the WATCHMAN Device is contraindicated * Ligated or oversewn left atrium * Concurrent participation in any investigational study. * Subject likely to not be available to co…